Agustos 2009
Üst gastrointestinal sistem endoskopisi yapilmis hastalarda Hepatit B ve Hepatit C sikligi
The prevalence of Hepatitis B and C in patients with upper gastrointestinal endoscopy
- Ana Sayfa
- Sayılar
- Agustos 2009
- Üst gastrointestinal sistem endoskopisi yapilmis hastalarda Hepatit B ve Hepatit C sikligi...
Özet
Giris ve Amaç: Bu çalismada, üst gastrointestinal sistem endoskopisi yapilmis hastalarda hepatit C ve hepatit B sikligi arastirilip, üst gastrointestinal sistem endoskopisi yapilmamis popülasyonla karsilastirilmasi amaçlanmistir. Gereç ve Yöntem: Poliklinigimize basvuran üst gastrointestinal sistem endoskopisi yapilmis olan hastalardan (grup A), HbsAg, anti-Hbs, anti-HCV göstergeleri istendi. Geçirilmis sarilik öyküsü olan, hepatit B asisi uygulanmis olan ve son 3 ay içerisinde üst gastrointestinal sistem endoskopisi yapilmis olan hastalar çalismaya dahil edilmedi. Hasta sayisi için üst sinir 300 olarak belirlendi. Kontrol grubu olarak (grup B), poliklinigimize herhangi bir sikayetle basvuran, üst gastrointestinal sistem endoskopisi yapilmamis 100 hasta seçildi. Kontrol grubundan da ayni hepatit göstergeleri istendi. Bulgular: Grup A?daki 300 hastanin 206 (%68)?si kadin, 94 (%32)?ü erkekti. Yas ortalamasi bu grupta 46.6?ydi. 300 hastanin, 10 (%3.3)?unda HbsAg pozitif, 2 (%0.6)?sinde anti-HCV pozitif, 95(%31)?inde anti-Hbs pozitif saptandi. Grup B?deki 100 hastanin 74?ü erkek, 26?si kadindi. Yas ortalamasi bu grupta 45.1?di. 100 hastanin 3 (%3)?ünde HbsAg pozitif, 1 (%1)?inde anti-HCV pozitif, 23 (%23)?ünde anti-Hbs pozitif saptandi. 2 grup arasindaki bu fark istatiksel olarak anlamli bulunmadi. Sonuç: Iki grup arasinda hepatit B ve hepatit C göstergeleriyle yapilan taramada istatiksel olarak anlamli farklilik bulunmamistir. Bu bulgular gösterir ki; daha önce gastroskopi yapilmis hastalarda hepatit B ve hepatit C sikligi diger hastalara göre farkli degildir.
Abstract
Background and Aims: The aim of this study was to investigate the prevalence of hepatitis B and hepatitis C infections in patients undergoing upper gastrointestinal endoscopy (Group A) and to compare the prevalence of this population with that of a control group of patients with no history of upper gastrointestinal endoscopy (Group B). Materials and Methods: HbsAg, anti-Hbs and anti-HCV parameters were tested in both groups. Patients who had an acute-chronic hepatitis or passive immunization in their hepatitis B history or who had any endoscopic procedure during the last three months were excluded from the study. Three hundred patients in Group A and 100 controls in Group B were included in the study. Results: In Group A, 68% of patients were female and 32% were male, and their mean age was 46. Ten (3.3%) of the 300 patients were HbsAg-positive, 2 (0.6%) were anti-HCV- positive and 95 (31%) were anti-Hbs-positive. In Group B, 74% of patients were male and 26% were female, and their mean age was 45.1. Three (3%) of the 100 patients were HbsAg-positive, 1 (1%) anti-HCV-positive and 23 (23%) anti-Hbs-positive. Conclusions: A comparison of the two groups for hepatitis B and hepatitis C parameters demonstrated no statistically significant differences between them. Our findings show that the prevalence of hepatitis B and C in patients who undergo gastroscopy does not differ when compared to other patients
